References
Albanesi C, Scarponi C, Giustizieri ML and Girolomoni G (2005) Keratinocytes in inflammatory skin diseases. Current Drug Targets – Inflammation and Allergy 4 (3): 329–334.
Albanesi C and Pastore S (2010) Pathobiology of chronic inflammatory skin diseases: interplay between keratinocytes and immune cells as a target for anti‐inflammatory drugs. Current Drug Metabolism 11 (3): 210–227.
Balato A, Unumatz D and Gaspari AA (2009) Natural killer T cells: an unconventional T‐cell subset with diverse effector and regulatory functions. Journal of Investigative Dermatology 129 (7): 1628–1643.
Balato A, Zhao Y, Harberts E, et al. (2012) CD1d‐dependent, iNKT‐cell cytotoxicity against keratinocytes in allergic contact dermatitis. Experimental Dermatology 21 (12): 915–920.
Beck B and Blanpain C (2012) Mechanisms regulating epidermal stem cells. EMBO Journal 31 (9): 2067–2075.
Broccardo CJ, Mahaffey S, Schwarz J, et al. (2011) Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and Staphylococcus aureus colonization. Journal of Allergy and Clinical Immunology 127 (1): 186–193.
Brogden NK, Mehalick L, Fischer CL, Wertz PW and Brogden KA (2012) The emerging role of peptides and lipids as antimicrobial epidermal barriers and modulators of local inflammation. Skin Pharmacology and Physiology 25 (4): 167–181.
Brown SJ, Kroboth K, Sandilands A, et al., et al. (2012) Intragenic copy number variation within filaggrin contributes to the risk of atopic dermatitis with a dose‐dependent effect. Journal of Investigative Dermatology 132 (1): 98–104.
Büchau AS (2010) EGFR (trans)activation mediates IL‐8 and distinct human antimicrobial peptide and protein production following skin injury. Journal of Investigative Dermatology 130 (4): 929–932.
Candi E, Schmidt R and Melino G (2005) The cornified envelope: a model of cell death in the skin. Nature Reviews. Molecular and Cell Biology 6 (4): 328–340.
Cookson W (2004) The immunogenetics of asthma and eczema: a new focus on the epithelium. Nature Reviews in Immunology 4 (12): 978–988.
De Benedetto A, Agnihothri R, McGirt LY, Bankova LG and Beck LA (2009) Atopic dermatitis: a disease caused by innate immune defects? Journal of Investigative Dermatology 129 (1): 14–30.
De Nardo D (2015) Toll‐like receptors: Activation, signalling and transcriptional modulation. Cytokine 74 (2): 181–189. DOI: 10.1016/j.cyto.2015.02.025 [Epub ahead of print].
Divekar R and Kita H (2015) Recent advances in epithelium‐derived cytokines (IL‐33, IL‐25, and thymic stromal lymphopoietin) and allergic inflammation. Current Opinion in Allergy and Clinical Immunology 15 (1): 98–103.
Dürr M and Peschel A (2002) Chemokines meet defensins: the merging concepts of chemoattractants and antimicrobial peptides in host defense. Infection and Immunity 70 (12): 6515–6517.
Elias PM, Eichenfield LF, Fowler JF Jr Horowitz P and McLeod RP (2013) Update on the structure and function of the skin barrier: atopic dermatitis as an exemplar of clinical implications. Seminars in Cutaneous Medicine and Surgery 32 (2 Suppl 2): S21–S24.
Fujita H (2013) The role of IL‐22 and Th22 cells in human skin diseases. Journal of Dermatological Science 72 (1): 3–8.
Gallo RL and Hooper LV (2012) Epithelial antimicrobial defence of the skin and intestine. Nature Reviews of Immunology 12 (7): 503–516.
Gittler JK, Shemer A, Suarez‐Farinas M, et al. (2012) Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. Journal of Allergy and Clinical Immunology 130 (6): 1344–1354.
Haertel E, Werner S and Schäfer M (2014) Transcriptional regulation of wound inflammation. Seminars in Immunology 26 (4): 321–328.
Homey B, Steinhoff M, Ruzicka T and Leung DYM (2006) Cytokines and chemokines orchestrate atopic skin inflammation. Journal of Allergy and Clinical Immunology 118 (1): 178–189.
Hornef MW and Bogdan C (2005) The role of epithelial Toll‐like receptor expression in host defense and microbial tolerance. Journal of Endotoxin Research 11 (2): 124–128.
Irvine AD, McLean WH and Leung DY (2011) Filaggrin mutations associated with skin and allergic diseases. New England Journal of Medicine 365 (14): 1315–1327.
Iwasaki A and Medzhitov R (2004) Toll‐like receptor control of the adaptive immune responses. Nature Immunology 5 (10): 987–995.
Kaesler S, Volz T, Skabytska Y, et al. (2014) Toll‐like receptor 2 ligands promote chronic atopic dermatitis through IL‐4‐mediated suppression of IL‐10. Journal of Allergy and Clinical Immunology 134 (1): 92–99.
Kirschner N, Rosenthal R, Furuse M, Moll I and Brandner JM (2013) Contribution of tight junction proteins to ion, macromolecule, and water barrier in keratinocytes. Journal of Investigative Dermatology 133 (5): 1161–1169.
Kuo IH, Yoshida T, De Benedetto A and Beck LA (2013) The cutaneous innate immune response in patients with atopic dermatitis. Journal of Allergy and Clinical Immunology 131 (2): 266–278.
Kypriotou M, Huber M and Hohl D (2012) The human epidermal differentiation complex: cornified envelope precursors, S100 proteins and the 'fused genes' family. Experimental Dermatology 21 (9): 643–649.
Leung DY (2013) New insights into atopic dermatitis: role of skin barrier and immune dysregulation. Allergology International 62 (2): 151–161.
Lichtenberger BM, Gerber PA, Holcmann M, et al. (2013) Epidermal EGFR controls cutaneous host defense and prevents inflammation. Science Translational Medicine 5 (199): 199ra111.
Lund S, Walford HH and Doherty TA (2013) Type 2 innate lymphoid cells in allergic disease. Current Immunological Reviews 9 (4): 214–221.
Martin P and Leibovich SJ (2005) Inflammatory cells during wound repair: the good, the bad and the ugly. Trends in Cell Biology 15 (11): 599–607.
Meister M, Tounsi A, Gaffal E, et al. (2015) Self‐antigen presentation by keratinocytes in the inflamed adult skin modulates T‐Cell auto‐reactivity. Journal of Investigative Dermatology. DOI: 10.1038/jid.2015.130 [Epub ahead of print].
Miajlovic H, Fallon PG, Irvine AD and Foster TJ (2010) Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus. Journal of Allergy and Clinical Immunology 126 (6): 1184–1190.
Moy AP, Murali M, Kroshinsky D, Duncan LM and Nazarian RM (2015) Immunologic overlap of helper T‐cell subtypes 17 and 22 in erythrodermic psoriasis and atopic dermatitis. JAMA Dermatology. DOI: 10.1001/jamadermatol.2015.2 [Epub ahead of print].
Mullin JM, Agostino N, Rendon‐Huerta E and Thornton JJ (2005) Epithelial and endothelial barriers in human disease. Drug Discovery Today 10 (6): 395–408.
Nakai K, Yoneda K, Hosokawa Y, et al. (2012) Reduced expression of epidermal growth factor receptor, E‐cadherin, and occludin in the skin of flaky tail mice is due to filaggrin and loricrin deficiencies. American Journal of Pathology 181 (3): 969–977.
Nestle FO, Di Meglio P, Qin JZ and Nickoloff BJ (2009) Skin immune sentinels in health and disease. Nature Reviews in Immunology 9 (10): 679–691.
Nograles KE, Zaba LC, Shemer A, et al. (2009) IL‐22‐producing ‘T22’ T cells account for upregulated IL‐22 in atopic dermatitis despite reduced IL‐17‐producing TH17 T cells. Journal of Allergy and Clinical Immunology 123 (6): 1244–1252.
Ong PY and Leung DY (2010) The infectious aspects of atopic dermatitis. Immunology and Allergy Clinics of North America 30 (3): 309–321.
Pastore S, Mascia F and Girolomoni G (2006) The contribution of keratinocytes to the pathogenesis of atopic dermatitis. European Journal of Dermatology 16 (2): 125–131.
Pastore S, Mascia F, Mariani V and Girolomoni G (2008) The epidermal growth factor receptor system in skin repair and inflammation. Journal of Investigative Dermatology 128 (6): 1365–1374.
Pastore S, Lulli D and Girolomoni G (2014) Epidermal growth factor receptor signalling in keratinocyte biology: implications for skin toxicity of tyrosine kinase inhibitors. Archives of Toxicology 88 (12): 1189–1203.
Roupé KM, Nybo M, Sjöbring U, et al. (2010) Injury is a major inducer of epidermal innate immune responses during wound healing. Journal of Investigative Dermatology 130 (4): 1167–1177.
Sääf A, Pivarcsi A, Winge MC, et al. (2012) Characterization of EGFR and ErbB2 expression in atopic dermatitis patients. Archives of Dermatological Research 304 (10): 773–780.
Sanchez DA, Nosanchuk JD and Friedman AJ (2015) The skin microbiome: is there a role in the pathogenesis of atopic dermatitis and psoriasis? Journal of Drugs in Dermatology 14 (2): 127–130.
Selsted ME and Ouellette AJ (2005) Mammalian defensins in the antimicrobial immune response. Nature Immunology 6 (6): 551–557.
Spergel JM (2010) From atopic dermatitis to asthma: the atopic march. Annals of Allergy, Asthma, and Immunology 105 (2): 99–106.
Zhang Z, Xiao C, Gibson AM, Bass SA and Khurana Hershey GK (2014) EGFR signaling blunts allergen‐induced IL‐6 production and Th17 responses in the skin and attenuates development and relapse of atopic dermatitis. Journal of Immunology 192 (3): 859–866.
Ziegler SF (2012) Thymic stromal lymphopoietin and allergic disease. Journal of Allergy and Clinical Immunology 130 (4): 845–852.
Further Reading
Belkaid Y and Segre JA (2014) Dialogue between skin microbiota and immunity. Science 346 (6212): 954–959.
Brubaker SW, Bonham KS, Zanoni I and Kagan JC (2015) Innate immune pattern recognition: a cell biological perspective. Annual Reviews of Immunology 33: 257–290.
Esche C, Stellato C and Beck LA (2005) Chemokines: key players in innate and adaptive immunity. Journal of Investigative Dermatology 125 (4): 615–628.
Ganz T (2003) Defensins: antimicrobial peptides of innate immunity. Nature Reviews in Immunology 3 (9): 710–720.
Girolomoni G, Mascia F, Dattilo C, Giannetti A and Pastore S (2006) Keratinocytes in atopic eczema. In: Ring J, Przybilla B and Ruzicka T (eds) Handbook of Atopic Eczema, pp. 332–339. Berlin: Springer.
McInturff JE, Modlin RL and Kim J (2005) The role of toll‐like receptors in the pathogenesis and treatment of dermatological disease. Journal of Investigative Dermatology 125 (1): 1–8.
Pastore S, Cavani A, Albanesi C and Girolomoni G (2005) Chemokines of human skin. In: Bos JD (ed) Skin Immune System. Cutaneous Immunology and Clinical Immunodermatology, pp. 373–392. Boca Raton, FL: CRC Press.
Peng W and Novak N (2015) Pathogenesis of atopic dermatitis. Clinical and Experimental Allergy 45 (3): 566–574.
Segre JA (2006) Epidermal barrier formation and recovery in skin disorders. Journal of Clinical Investigation 116 (5): 1150–1158.